XML 70 R62.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholders' Equity (Details) - USD ($)
 1 Months Ended 3 Months Ended
Apr. 30, 2021
Mar. 31, 2019
Dec. 31, 2017
Jul. 31, 2017
Jun. 30, 2017
Oct. 31, 2016
Feb. 29, 2016
Jun. 30, 2010
Sep. 30, 1995
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Dec. 31, 2021
Jun. 10, 2020
Jun. 14, 2018
Stockholders' Equity (Details) [Line Items]                              
Gross proceeds (in Dollars) $ 4,233,026 $ 9,000,002 $ 3,049,991       $ 5,900,003     $ 5,840        
Common stock shares sold 515,156 1,636,364 417,807       1,123,810                
Sale of stock, per share (in Dollars per share) $ 8.25 $ 5.5 $ 7.3       $ 5.25                
Net proceeds (in Dollars) $ 4,250,038 $ 8,303,436 $ 2,734,173       $ 5,313,224                
Stock option and incentive plan, description         In June 2017, our stockholders approved the 2017 Stock Option and Incentive Plan (the “2017 Plan”) pursuant to the provisions of the Internal Revenue Code of 1986, under which employees and certain service providers may be granted options to purchase shares of the Company’s common stock at no less than fair market value on the date of grant. At that time, 300,000 shares of common stock were reserved for issuance under the 2017 Plan. An amendment to the 2017 Plan increasing the number of shares reserved for issuance under the 2017 Plan from 300,000 shares to 650,000 shares was approved by a vote of stockholders at the Annual Meeting of Stockholders in June 2022.                    
Exercised stock options covering shares                     1,000        
Exercised stock options covering amount (in Dollars)                     $ 5,840        
Option outstanding of exercise price (in Dollars per share)                   $ 6.93   $ 7.19 $ 6.94    
Share-based payment, description                   The 84,000 stock options granted during the three-month period ended March 31, 2023 had exercise prices of $5.22 per share.          
Stock options exercise price (in Dollars)                     5,840        
Common stock purchase price (in Dollars per share)                 $ 70            
Exercisable and transferable, description                   The Rights (as amended) become exercisable and transferable apart from the common stock upon the earlier of i) 10 days following a public announcement that a person or group (Acquiring Person) has, without the prior consent of the Continuing Directors (as such term is defined in the Rights Agreement), acquired beneficial ownership of 20% or more of the outstanding common stock or ii) 10 days following commencement of a tender offer or exchange offer the consummation of which would result in ownership by a person or group of 20% or more of the outstanding common stock (the earlier of such dates being called the Distribution Date).           
Purchase price (in Dollars per share)                   $ 70          
Common stock were changed percentage                   50.00%          
Price per Right                   0.005          
Extend the rights plan, description                   Our Board of Directors decided to seek an advisory vote by stockholders at the Annual Meeting of Stockholders held in June 2022, as to whether to extend the Rights Plan by one year to September 19, 2023. Of the votes actually cast on this proposal, 65% voted in favor, 32% voted against and 3% abstained. On the basis of this vote, our Board of Directors voted to extend the Rights Plan by one year to September 19, 2023. Our Board of Directors decided to seek another advisory vote by stockholders at the Annual Meeting of Stockholders to be held on June 15, 2023, as to whether to extend the Rights Plan by another year to September 19, 2024. Recognizing that there might be a substantial number of broker non-votes, our Board of Directors disclosed that it would be guided by the votes actually cast on this proposal in deciding whether to extend the expiration date of such plan by one year.          
Common stock, shares authorized                   15,000,000   15,000,000      
2010 Plan [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Common stock outstanding under the plan               300,000   202,500   202,500      
Stock option expiration period               10 years              
Weighted average remaining life of options outstanding                   7 years          
Weighted average remaining life of options exercisable                   4 years          
2017 Plan [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Common stock outstanding under the plan                   423,500   402,500      
Stock option expiration period         10 years                    
Weighted average remaining life of options exercisable                   4 months          
Minimum [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Percentage of acquiring person                   20.00%          
Common stock, shares authorized                           11,000,000 8,000,000
Minimum [Member] | 2010 Plan [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Option outstanding of exercise price (in Dollars per share)                   $ 4          
Maximum [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Percentage of acquiring person                   20.00%          
Common stock, shares authorized                           15,000,000 11,000,000
Maximum [Member] | 2010 Plan [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Option outstanding of exercise price (in Dollars per share)                   $ 10.04          
Private Placement [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Gross proceeds (in Dollars)           $ 3,464,370                  
Common stock shares sold           659,880                  
Net proceeds (in Dollars)           $ 3,160,923                  
Closing share price (in Dollars per share)           $ 5.25                  
Acquiring Person [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Acquisition percentage                   50.00%          
Investor [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Gross proceeds (in Dollars)       $ 1,050,000                      
Net proceeds (in Dollars)       $ 1,034,164                      
Closing share price (in Dollars per share)       $ 5.25                      
Common stock shares issued       200,000                      
February 2016 to April 2021 [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Potential issuance or sale of equity (in Dollars)                   $ 4,553,017          
Gross proceeds (in Dollars)                   $ 26,714,403          
Weighted average price (in Dollars per share)                   $ 5.87          
Employee Stock Option [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Share-based payment, description                   As of March 31, 2023, total unrecognized stock-based compensation related to non-vested stock options aggregated $905,795, which will be recognized over a weighted average remaining period of approximately 2 years and 1 month.          
Stock options granted                   2.88          
Employee Stock Option [Member] | Minimum [Member]                              
Stockholders' Equity (Details) [Line Items]                              
Stock options exercise price (in Dollars)                     $ 4.26